Preamble
p. pp. 34-36
to correct for this mismatch between control and treatment data, all treatment data without the corresponding control hourly usage data was removed from the analysis, refer to [Figure 9b](#page-35-0). Figure 9: Hourly Data Completeness in...
AI summary The analysis discusses data completeness for the Phase 5 MURB TOU EM&V analysis, highlighting that 60.2% of data was usable after removing unpaired treatment data. NS Power used a DiD regression approach similar to Phase 4 for reliability, despite incomplete control group AMI data.